PDK1-mTOR signaling pathway inhibitors reduce cell proliferation in MK2206 resistant neuroblastoma cells

PURPOSE: AKT plays a pivotal role in the signal transduction of cancer cells. MK2206, an AKT inhibitor, has been shown to be an effective anti-cancer drug to a variety of cancer cell lines. However, some cancer cells acquire resistance to MK2206 and new strategies to suppress these cell lines remain...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Cancer Cell Int
Main Authors: Qi, Lei, Toyoda, Hidemi, Xu, Dong-qing, Zhou, Ye, Sakurai, Naoto, Amano, Keishirou, Kihira, Kentaro, Hori, Hiroki, Azuma, Eiichi, Komada, Yoshihiro
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2015
Assuntos:
Primary Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4587771/
https://ncbi.nlm.nih.gov/pubmed/26421002
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12935-015-0239-4
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados